MRNA therapy takes on Hard-to-Treat blood cancer
NCT ID NCT07116616
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 15 times
Summary
This study tests an experimental mRNA medicine called mRNA-2808 in people whose multiple myeloma has returned or stopped responding to standard treatments. The main goals are to check safety and see if the treatment can shrink tumors or slow the cancer. About 166 adults will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Levine Cancer Institute
NOT_YET_RECRUITINGCharlotte, North Carolina, 28204, United States
-
Emory University Hospital
RECRUITINGAtlanta, Georgia, 30322, United States
-
Mass General Brigham
NOT_YET_RECRUITINGBoston, Massachusetts, 02114, United States
-
Memorial Sloan-Kettering Cancer Center
NOT_YET_RECRUITINGNew York, New York, 10065, United States
-
Penn Medicine
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203, United States
-
The Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Tisch Cancer Institute at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
-
UCSF
NOT_YET_RECRUITINGSan Francisco, California, 94143, United States
-
University of Alabama at Birmingham Hospital
RECRUITINGBirmingham, Alabama, 35233, United States
Conditions
Explore the condition pages connected to this study.